Eminence Capital, LP Laboratory Corp Of America Holdings Transaction History

Eminence Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $96.7 Million - $112 Million	-355,934 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $97.8 Million - $110 Million	355,934 New	355,934 $100 Million
Q2 2021 Aug 16, 2021	SELL	$251.87 - $278.14 $135 Million - $149 Million	-536,077 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $16.1 Million - $20 Million	-78,357 Reduced 12.75%	536,077 $137 Million
Q4 2020 Feb 16, 2021	BUY	$186.91 - $214.42 $87 Million - $99.8 Million	465,553 Added 312.7%	614,434 $125 Million
Q3 2020 Nov 16, 2020	BUY	$167.03 - $201.3 $2.35 Million - $2.84 Million	14,096 Added 10.46%	148,881 $28 Million
Q2 2020 Aug 17, 2020	BUY	$113.31 - $182.44 $15.3 Million - $24.6 Million	134,785 New	134,785 $22.4 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Eminence Capital, LP with notifications on news.